DUBLIN, Nov. 17, 2021 /PRNewswire/ -- The "Advanced Glycation End Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
This report on the global advanced glycation end products market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031.
The report provides revenue of the global advanced glycation end products market for the period from 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global advanced glycation end products market from 2021 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the advanced glycation end products market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global advanced glycation end products market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global advanced glycation end products market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global advanced glycation end products market.
The report delves into the competitive landscape of the global advanced glycation end products market. Key players operating in the global advanced glycation end products market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global advanced glycation end products market profiled in this report.
Key Questions Answered in Advanced Glycation End Products Market Report
- What is the sales/revenue generated by the advanced glycation end products market across all regions during the forecast period?
- What are the opportunities in the global advanced glycation end products market?
- What are the major drivers, restraints, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which type segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Key Topics Covered:
1. Preface
2. Assumptions and Research Methodology
3. Executive Summary : Global Advanced Glycation End Products Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Advanced Glycation End Products Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Bioactivity of AGEs and RAGE: Flowchart
5.2. Key Trend Analysis
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)
6. Global Advanced Glycation End Products Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
6.3.1. Non-fluorescent AGEs
6.3.1.1. Carboxymethyl-lysine (CML)
6.3.1.2. Carboxyethyl-lysine (CEL)
6.3.1.3. Pyrraline
6.3.2. Fluorescent AGEs
6.3.2.1. Pentosidine
6.3.2.2. Methylglyoxal-lysine dimer (MOLD)
6.4. Global Advanced Glycation End Products Market Attractiveness, by Type
7. Global Advanced Glycation End Products Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
7.3.1. Diabetic Complications
7.3.2. Cancer
7.3.3. Bone Diseases
7.3.4. Neurodegenerative Diseases
7.3.5. Others
7.4. Global Advanced Glycation End Products Market Attractiveness, by Application
8. Global Advanced Glycation End Products Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Global Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Others
8.4. Global Advanced Glycation End Products Market Attractiveness, by End-user
9. Global Advanced Glycation End Products Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Advanced Glycation End Products Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Advanced Glycation End Products Market Attractiveness, by Country/Region
10. North America Advanced Glycation End Products Market Analysis and Forecast
10.1. Introduction
10.2. North America Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
10.3. North America Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
10.4. North America Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
10.5. North America Advanced Glycation End Products Market Value Forecast, by Country, 2017-2031
10.6. North America Advanced Glycation End Products Market Attractiveness Analysis
11. Europe Advanced Glycation End Products Market Analysis and Forecast
11.1. Introduction
11.2. Europe Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
11.3. Europe Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
11.4. Europe Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
11.5. Europe Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
11.6. Europe Advanced Glycation End Products Market Attractiveness Analysis
12. Asia Pacific Advanced Glycation End Products Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
12.3. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
12.4. Asia Pacific Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
12.5. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
12.6. Asia Pacific Advanced Glycation End Products Market Attractiveness Analysis
13. Latin America Advanced Glycation End Products Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
13.3. Latin America Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
13.4. Latin America Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
13.5. Latin America Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
13.6. Latin America Advanced Glycation End Products Market Attractiveness Analysis
14. Middle East & Africa Advanced Glycation End Products Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
14.3. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
14.4. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
14.5. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
14.6. Middle East & Africa Advanced Glycation End Products Market Attractiveness Analysis
15. Competition Landscape
15.1. Market Share Analysis, by Company (2020)
15.2. Company Profiles
15.2.1. AbbVie, Inc. (Allergan Plc)
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Company Financials
15.2.1.3. Growth Strategies
15.2.1.4. SWOT Analysis
15.2.2. Merck KGaA
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Company Financials
15.2.2.3. Growth Strategies
15.2.2.4. SWOT Analysis
15.2.3. Takeda Pharmaceutical Company Limited
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Company Financials
15.2.3.3. Growth Strategies
15.2.3.4. SWOT Analysis
15.2.4. Estee Lauder Companies
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Company Financials
15.2.4.3. Growth Strategies
15.2.4.4. SWOT Analysis
15.2.5. Shiseido Company, Limited
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Company Financials
15.2.5.3. Growth Strategies
15.2.5.4. SWOT Analysis
15.2.6. Beiersdorf AG
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Company Financials
15.2.6.3. Growth Strategies
15.2.6.4. SWOT Analysis
15.2.7. L'Oreal S.A.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Company Financials
15.2.7.3. Growth Strategies
15.2.7.4. SWOT Analysis
15.2.8. NuFACE
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Company Financials
15.2.8.3. Growth Strategies
15.2.8.4. SWOT Analysis
15.2.9. Rodan & Fields
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Company Financials
15.2.9.3. Growth Strategies
15.2.9.4. SWOT Analysis
15.2.10. PhotoMedex, Inc.
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Company Financials
15.2.10.3. Growth Strategies
15.2.10.4. SWOT Analysis
15.2.11. Ostium Cosmetics
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Company Financials
15.2.11.3. Growth Strategies
15.2.11.4. SWOT Analysis
15.2.12. Cell Biolabs, Inc.
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Company Financials
15.2.12.3. Growth Strategies
15.2.12.4. SWOT Analysis
15.2.13. Shanghai Korain Biotech Co., Ltd.
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Company Financials
15.2.13.3. Growth Strategies
15.2.13.4. SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/hhl3dd
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article